Your browser doesn't support javascript.
loading
Usefulness of an HIV DNA resistance genotypic test in patients who are candidates for a switch to the rilpivirine/emtricitabine/tenofovir disoproxil fumarate combination.
Lambert-Niclot, S; Allavena, C; Grude, M; Flandre, P; Sayon, S; Andre, E; Wirden, M; Rodallec, A; Jovelin, T; Katlama, C; Calvez, V; Raffi, F; Marcelin, A-G.
Affiliation
  • Lambert-Niclot S; Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1136, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpital Pitié-Salpêtrière, Service de Virologie, Paris F-75013, France sidonie.lambert@psl.aphp.fr.
  • Allavena C; Infectious Diseases Department, University Hospital of Nantes, Nantes, France.
  • Grude M; Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1136, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpital Pitié-Salpêtrière, Service de Virologie, Paris F-75013, France.
  • Flandre P; Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1136, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpital Pitié-Salpêtrière, Service de Virologie, Paris F-75013, France.
  • Sayon S; Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1136, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpital Pitié-Salpêtrière, Service de Virologie, Paris F-75013, France.
  • Andre E; Virology, University Hospital of Nantes, Nantes, France.
  • Wirden M; Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1136, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpital Pitié-Salpêtrière, Service de Virologie, Paris F-75013, France.
  • Rodallec A; Virology, University Hospital of Nantes, Nantes, France.
  • Jovelin T; Infectious Diseases Department, University Hospital of Nantes, Nantes, France.
  • Katlama C; Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpital Pitié-Salpêtrière, Service de maladies Infectieuses, Paris F-75013, France.
  • Calvez V; Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1136, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpital Pitié-Salpêtrière, Service de Virologie, Paris F-75013, France.
  • Raffi F; Infectious Diseases Department, University Hospital of Nantes, Nantes, France.
  • Marcelin AG; Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1136, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpital Pitié-Salpêtrière, Service de Virologie, Paris F-75013, France.
J Antimicrob Chemother ; 71(8): 2248-51, 2016 08.
Article in En | MEDLINE | ID: mdl-27231280
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: DNA, Viral / HIV Infections / Anti-HIV Agents / Drug Resistance, Viral / Rilpivirine / Tenofovir / Emtricitabine Type of study: Evaluation_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Antimicrob Chemother Year: 2016 Type: Article Affiliation country: France
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: DNA, Viral / HIV Infections / Anti-HIV Agents / Drug Resistance, Viral / Rilpivirine / Tenofovir / Emtricitabine Type of study: Evaluation_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Antimicrob Chemother Year: 2016 Type: Article Affiliation country: France